Profile data is unavailable for this security.
About the company
Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
- Revenue in USD (TTM)3.92bn
- Net income in USD462.28m
- Incorporated1997
- Employees21.61k
- LocationAlign Technology Inc410 North Scottsdale Road, Suite 1300TEMPE 85288United StatesUSA
- Phone+1 (408) 470-1000
- Fax+1 (408) 470-1010
- Websitehttps://www.aligntech.com/
Mergers & acquisitions
| Acquired company | ALGN:NSQ since announced | Transaction value |
|---|---|---|
| Cubicure GmbH | -29.16% | 84.69m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teleflex Inc | 3.00bn | 296.02m | 10.03bn | 14.50k | 34.04 | 2.23 | 18.43 | 3.34 | 6.26 | 6.23 | 63.41 | 95.61 | 0.417 | 2.14 | 6.99 | 206,993.50 | 4.11 | 5.86 | 4.47 | 6.42 | 55.70 | 55.04 | 9.86 | 14.62 | 1.41 | 7.67 | 0.2808 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
| Shockwave Medical Inc | 787.97m | 163.50m | 12.38bn | 1.47k | 77.25 | 16.04 | 70.62 | 15.71 | 4.27 | 4.27 | 20.58 | 20.55 | 0.6493 | 1.05 | 7.55 | 536,763.60 | 13.47 | 10.29 | 14.91 | 11.39 | 86.99 | 84.69 | 20.75 | 15.14 | 12.61 | -- | 0.4936 | 0.00 | 49.11 | 126.45 | -31.81 | -- | 72.88 | -- |
| Insulet Corp | 1.78bn | 234.00m | 12.80bn | 3.00k | 56.91 | 16.19 | 41.51 | 7.19 | 3.21 | 3.21 | 23.61 | 11.29 | 0.7249 | 1.36 | 6.62 | 593,566.70 | 9.53 | 2.71 | 11.42 | 3.14 | 68.86 | 65.81 | 13.14 | 4.28 | 2.75 | 65.58 | 0.6393 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
| Hologic Inc | 3.96bn | 466.50m | 17.40bn | 6.99k | 38.35 | 3.59 | 22.15 | 4.39 | 1.94 | 1.94 | 16.30 | 20.76 | 0.4361 | 2.66 | 5.82 | 566,609.40 | 5.14 | 11.40 | 5.74 | 13.38 | 55.12 | 60.29 | 11.78 | 20.95 | 3.29 | -- | 0.3465 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
| Baxter International Inc | 14.89bn | -38.00m | 17.56bn | 60.00k | -- | 2.15 | 14.06 | 1.18 | -0.0762 | 5.21 | 29.33 | 16.04 | 0.5311 | 3.21 | 5.71 | 248,200.00 | -0.107 | 0.1942 | -0.1338 | 0.2333 | 36.31 | 38.20 | -0.2015 | 0.3674 | 1.01 | 3.58 | 0.625 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
| Cooper Companies Inc | 3.67bn | 290.80m | 19.23bn | 15.00k | 97.78 | 2.50 | 28.89 | 5.25 | 0.9896 | 0.9896 | 7.36 | 38.73 | 0.3108 | 1.77 | 5.95 | 244,420.00 | 2.47 | 10.06 | 2.68 | 11.34 | 66.09 | 65.54 | 7.93 | 29.00 | 1.08 | 4.92 | 0.2649 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
| Align Technology, Inc. | 3.92bn | 462.28m | 19.88bn | 21.61k | 43.49 | 5.29 | 33.03 | 5.07 | 6.07 | 6.07 | 51.44 | 49.94 | 0.6497 | 3.96 | 4.27 | 181,237.60 | 7.67 | 16.34 | 11.51 | 24.14 | 70.06 | 71.72 | 11.80 | 23.16 | 1.09 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
| Steris PLC | 5.44bn | 532.54m | 22.79bn | 17.00k | 42.95 | 3.61 | 28.07 | 4.19 | 5.37 | 3.81 | 54.85 | 63.91 | 0.4971 | 4.51 | 5.62 | -- | 4.88 | 4.03 | 5.32 | 4.41 | 43.23 | 43.50 | 9.82 | 8.20 | 2.34 | 8.76 | 0.3307 | 47.34 | 3.65 | 13.06 | 415.22 | 12.67 | 13.69 | 8.83 |
| Zimmer Biomet Holdings Inc | 7.45bn | 963.80m | 24.48bn | 18.00k | 25.76 | 1.94 | 12.73 | 3.29 | 4.62 | 4.62 | 35.72 | 61.24 | 0.3491 | 0.9052 | 5.27 | 414,027.80 | 4.52 | 2.21 | 5.14 | 2.52 | 71.89 | 71.25 | 12.95 | 7.28 | 0.802 | 7.32 | 0.315 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| West Pharmaceutical Services Inc. | 2.93bn | 568.70m | 24.55bn | 10.60k | 44.43 | 9.18 | 35.39 | 8.38 | 7.58 | 7.58 | 39.09 | 36.72 | 0.7995 | 4.20 | 5.65 | 276,283.00 | 15.08 | 15.61 | 17.99 | 18.65 | 37.15 | 38.06 | 18.86 | 18.47 | 1.95 | -- | 0.0714 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 8.06m | 10.70% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 4.07m | 5.40% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 3.05m | 4.06% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2024 | 1.83m | 2.43% |
| AllianceBernstein LPas of 31 Mar 2024 | 1.78m | 2.37% |
| BlackRock Advisors LLCas of 31 Mar 2024 | 1.75m | 2.33% |
| Geode Capital Management LLCas of 31 Mar 2024 | 1.72m | 2.29% |
| Sands Capital Management LLCas of 31 Mar 2024 | 1.36m | 1.80% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 1.26m | 1.67% |
| Brown Advisory LLCas of 31 Mar 2024 | 1.23m | 1.63% |
